Overview: EDA techniques can help you translate your data into useful and actionable insights.Discover how top analysts uncover patterns, eliminate errors, and ...

Late-breaking results from the Phase III NRG GY019 trial indicate that letrozole monotherapy (L) did not demonstrate ...

Strengthening the Shareholder Base of a Long‑Term Life‑Sciences Platform ABL Luxembourg has been built with a long‑term ...

Patients received an initial intratumoral injection of RP1 with up to 7 additional doses every 2 weeks, plus 240 mg nivolumab ...

Petrobras has confirmed a hydrocarbon discovery in a deepwater pre-salt well in Brazil’s Campos Basin, reinforcing its ...

Late breaking results from the phase III NRG GY019 trial indicate that letrozole monotherapy (L) did not demonstrate non inferiority to paclitaxel/carboplatin followed by letrozole (PC/L) for ...

In the i-TIMES study, researchers examined data from phase 2 and 3 randomized controlled trials that evaluated ICI therapy, alone or in combination, in patients with advanced NSCLC.

Late breaking results from the phase III NRG GY019 trial indicate that letrozole monotherapy (L) did not demonstrate non ...

Chainalysis launches AI agents to simplify blockchain analysis, helping teams detect crypto crime faster without specialist ...

This study presents a hybrid binder that lowers embodied carbon by 45% and boosts concrete strength and durability using ...

Muse by Interaxon today announced Smart Wakeup, the newest addition to its Sleep, by Design platform. Smart Wakeup monitors brain activity in real time and times a gentle audio wake-up to lighter ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...